RE:RE:RE:These News Releases By the Way Shouldn't Be Taken LightlyI am not worried it has a very small cap compared to its competition in this space I would be a lot more concerned if I had bought MMED or Trip at the peak.Whether any of these companies make money or not in 2021 there will still be a run on the stock as the world starts to follow the shroom
revolution in health care.The asian countries are 2000 years ahead of us in this field of study though.